NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL

Ehsan Tabari, Alexander F. Lovejoy, Hai Lin, Christopher R. Bolen, Seng Lor Saelee, Joshua P. Lefkowitz, David M. Kurtz, Alessia Bottos, Tina G. Nielsen, Joana M. Parreira & Khai T. Luong

• Manuscript: Tabari et al - Prognostic Impact of ctDNA in 1L DLBCL
• Supplementary Methods: GOYA_ctDNA_supplementary_methods_Leuk_Lymph_31Oct23.pdf
• Supplementary Table 1: Supplementary_Table_1.xlsx
• Supplementary Table 2A: Supplementary_Table_2A.xlsx
• Supplementary Table 2B: Supplementary_Table_2B.xlsx
• Supplementary Table 2C: Supplementary_Table_2C.xlsx
• Post-publication analyses with the publicly available data https://github.com/etabari/goya_paper